Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Dec-23 4:39 PM View:  | Edgewise Therapeutics, Inc. (EWTX) | 26-Dec-23 | Private Purchase | 10,857 | $9.30 | $100,958.00 | 100% 0 to 10.86K | |
| 28-Jan-21 7:50 PM View: | Eidos Therapeutics, Inc. (EIDX) | 26-Jan-21 | Disposition (change in control) | 380,467 | -- | -- | (100%) 380.47K to 0 | |
| 28-Jan-21 7:50 PM View: | Eidos Therapeutics, Inc. (EIDX) | 28-Dec-20 | Gift | 500 | -- | -- | (< 1%) 380.97K to 380.47K | |
| 18-Sep-20 4:06 PM View: | Eidos Therapeutics, Inc. (EIDX) | 17-Sep-20 | Market Sale (Planned) | 5,767 | $50.16 | $289,259.00 | (1%) 386.73K to 380.97K | (156%) |
| 16-Sep-20 6:35 PM View: | Eidos Therapeutics, Inc. (EIDX) | 16-Sep-20 | Market Sale (Planned) | 3,122 | $50.16 | $156,610.00 | (< 1%) 389.86K to 386.73K | (156%) |
| 16-Sep-20 6:35 PM View: | Eidos Therapeutics, Inc. (EIDX) | 15-Sep-20 | Market Sale (Planned) | 1,000 | $50.06 | $50,064.00 | (< 1%) 390.86K to 389.86K | (157%) |
| 16-Sep-20 6:35 PM View: | Eidos Therapeutics, Inc. (EIDX) | 14-Sep-20 | Market Sale (Planned) | 111 | $50.00 | $5,550.00 | (< 1%) 390.97K to 390.86K | (157%) |
| 09-Jul-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 07-Jul-20 | Market Sale (Planned) | 5,000 | $50.00 | $250,000.00 | (1%) 395.97K to 390.97K | (157%) |
| 01-Jul-20 4:06 PM View: | Eidos Therapeutics, Inc. (EIDX) | 29-Jun-20 | Acquisition (other) | 1,088 | -- | -- | < 1% 394.88K to 395.97K | |
| 05-Jun-20 4:06 PM View: | Eidos Therapeutics, Inc. (EIDX) | 03-Jun-20 | Market Sale (Planned) | 5,000 | $50.00 | $250,000.00 | (1%) 399.88K to 394.88K | (157%) |
| 05-Jun-20 4:06 PM View: | Eidos Therapeutics, Inc. (EIDX) | 02-Jun-20 | Gift | 1,020 | -- | -- | (< 1%) 400.9K to 399.88K | |
| 05-Jun-20 4:06 PM View: | Eidos Therapeutics, Inc. (EIDX) | 01-Jun-20 | Gift | 1,020 | -- | -- | (< 1%) 401.92K to 400.9K | |
| 05-Jun-20 4:06 PM View: | Eidos Therapeutics, Inc. (EIDX) | 31-May-20 | Grant | 444 | $41.57 | $18,458.60 | < 1% 401.48K to 401.92K | |
| 01-Jun-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 28-May-20 | Market Sale (Planned) | 5,000 | $50.00 | $250,000.00 | (1%) 406.48K to 401.48K | (157%) |
| 27-Apr-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 24-Apr-20 | Market Sale (Planned) | 2,153 | $50.00 | $107,650.00 | (< 1%) 408.63K to 406.48K | (157%) |
| 27-Apr-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 23-Apr-20 | Market Sale (Planned) | 2,847 | $50.00 | $142,350.00 | (< 1%) 411.48K to 408.63K | (157%) |
| 04-Mar-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 02-Mar-20 | Market Sale | 10,000 | $51.57 | $515,706.00 | (2%) 421.48K to 411.48K | (149%) |
| 19-Feb-20 6:05 AM View: | Eidos Therapeutics, Inc. (EIDX) | 13-Feb-20 | Market Sale | 10,000 | $54.00 | $540,000.00 | (2%) 431.48K to 421.48K | (138%) |
| 19-Feb-20 6:05 AM View: | Eidos Therapeutics, Inc. (EIDX) | 04-Feb-20 | Gift | 1,632 | -- | -- | (< 1%) 433.11K to 431.48K | |
| 16-Jan-20 6:35 PM View: | Eidos Therapeutics, Inc. (EIDX) | 15-Jan-20 | Market Sale | 3,580 | $55.00 | $196,900.00 | (< 1%) 436.69K to 433.11K | (133%) |
| 16-Jan-20 6:35 PM View: | Eidos Therapeutics, Inc. (EIDX) | 14-Jan-20 | Market Sale | 6,420 | $55.01 | $353,172.00 | (1%) 443.11K to 436.69K | (133%) |
| 09-Jan-20 6:53 PM View: | Eidos Therapeutics, Inc. (EIDX) | 30-Dec-19 | Gift | 100 | -- | -- | (< 1%) 443.21K to 443.11K | |
| 09-Jan-20 6:53 PM View: | Eidos Therapeutics, Inc. (EIDX) | 26-Dec-19 | Gift | 170 | -- | -- | (< 1%) 443.38K to 443.21K | |
| 05-Dec-19 7:31 PM View: | Eidos Therapeutics, Inc. (EIDX) | 04-Dec-19 | Market Sale | 10,000 | $58.90 | $589,048.00 | (2%) 453.38K to 443.38K | (118%) |
| 05-Dec-19 7:31 PM View: | Eidos Therapeutics, Inc. (EIDX) | 26-Nov-19 | Gift | 1,000 | -- | -- | (< 1%) 454.38K to 453.38K | |
| 27-Nov-19 9:00 PM View: | Eidos Therapeutics, Inc. (EIDX) | 25-Nov-19 | Market Sale | 10,000 | $56.52 | $565,218.00 | (2%) 464.38K to 454.38K | (127%) |
| 22-Nov-19 9:00 PM View: | Eidos Therapeutics, Inc. (EIDX) | 21-Nov-19 | Market Sale | 10,000 | $55.11 | $551,073.00 | (2%) 474.38K to 464.38K | (133%) |
| 19-Nov-19 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 18-Nov-19 | Market Sale (Planned) | 10,000 | $50.26 | $502,574.00 | (2%) 484.38K to 474.38K | (156%) |
| 19-Nov-19 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 15-Nov-19 | Market Sale (Planned) | 5,000 | $45.43 | $227,129.00 | (1%) 489.38K to 484.38K | (183%) |
| 16-Oct-19 4:58 PM View: | Eidos Therapeutics, Inc. (EIDX) | 15-Oct-19 | Market Sale (Planned) | 5,000 | $36.16 | $180,818.00 | (1%) 494.38K to 489.38K | (255%) |
| 18-Sep-19 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 16-Sep-19 | Market Sale (Planned) | 5,000 | $45.74 | $228,722.00 | (1%) 499.38K to 494.38K | (181%) |
| 19-Aug-19 7:18 PM View: | Eidos Therapeutics, Inc. (EIDX) | 15-Aug-19 | Market Sale (Planned) | 5,000 | $38.72 | $193,596.00 | (< 1%) 504.38K to 499.38K | (232%) |
| 17-Jul-19 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 15-Jul-19 | Market Sale | 15,000 | $40.04 | $600,561.00 | (3%) 519.38K to 504.38K | (221%) |
| 17-Jul-19 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 31-May-19 | Grant | 1,769 | $12.01 | $21,246.60 | < 1% 517.61K to 519.38K | |
| 31-May-19 4:17 PM View: | Eidos Therapeutics, Inc. (EIDX) | 30-May-19 | Market Sale | 5,000 | $32.64 | $163,178.00 | (< 1%) 521.53K to 516.53K | (293%) |
| 06-May-19 8:37 PM View: | Eidos Therapeutics, Inc. (EIDX) | 03-May-19 | Market Sale | 5,000 | $25.03 | $125,150.00 | (< 1%) 526.53K to 521.53K | (413%) |
| 03-May-19 9:52 PM View: | Eidos Therapeutics, Inc. (EIDX) | 01-May-19 | Market Sale | 5,000 | $25.46 | $127,287.00 | (< 1%) 532.61K to 527.61K | (404%) |
| 16-Apr-19 9:10 PM View: | Eidos Therapeutics, Inc. (EIDX) | 15-Apr-19 | Market Sale | 5,000 | $23.11 | $115,550.00 | (< 1%) 536.53K to 531.53K | (456%) |
| 03-May-19 9:52 PM View: | Eidos Therapeutics, Inc. (EIDX) | 30-Nov-18 | Grant | 1,081 | $12.01 | $12,982.80 | < 1% 531.53K to 532.61K | |
| 06-May-16 4:20 PM View: | Myokardia, Inc. (MYOK) | 29-Apr-16 | Grant | 1,807 | $8.50 | $15,359.50 | < 1% 239.19K to 241.0K | |
| 05-Nov-15 8:41 PM View: | Myokardia, Inc. (MYOK) | 03-Nov-15 | Purchase | 3,000 | $10.00 | $30,000.00 | 1% 236.19K to 239.19K |